Krumbholz, Manuela
Dolnik, Anna
Sträng, Eric
Ghete, Tabita
Skambraks, Sabrina
Hutter, Stephan
Simonis, Alfred
Stegelmann, Frank
Suttorp, Meinolf
Horn, Anselm H.C.
Sticht, Heinrich
Haferlach, Torsten
Bullinger, Lars
Metzler, Markus
Funding for this research was provided by:
Schornsteinfeger helfen krebskranken Kindern e.V., Germany
Sonnenstrahl e. V. Dresden, Germany
Bundesministerium für Bildung und Forschung,Germany (01GM2207F)
Article History
Received: 17 July 2024
Accepted: 2 September 2024
First Online: 26 September 2024
Declarations
:
: Not applicable.
: LB: honoraria from AbbVie, Amgen, Astellas, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Gilead, Hexal, Janssen, Jazz Pharmaceuticals, Menarini, Novartis, Pfizer, Roche, and Sanofi, as well as research support from Bayer and Jazz Pharmaceuticals. MS: honoraria from Novartis, Pfizer, Bristol-Myers Squibb. No potential conflicts of interest were disclosed by the other authors.
: For genetic analyses, all participants or legal guardians provided informed consent in accordance with the Declaration of Helsinki (pediatric CML: EK282 122 006, EK 236_18 B; adult CML: EK05117, EK3456-05/12).